Nimbus names Loh biology head
Biotechnology company Nimbus Therapeutics has named Christine Loh as SVP and head of biology. She was most recently VP of translational medicine at Kymera Therapeutics, where she worked on biomarker strategy, patient selection and resource-building initiatives.
JenaValve hires two
JenaValve Technology, a developer of a novel transcatheter aortic valve replacement system, has brought on Vinny Podichetty as VP of clinical affairs and Jeff Thiel as VP of operations. Podichetty was previously VP of global clinical and regulatory affairs at IRRAS, a medical technology company. Thiel was previously president and CEO of drug eluting stent company Devax.
CASI promotes Zhang
Biopharmaceutical company CASI Pharmaceuticals has promoted Larry Zhang to president. Zhang joined the company last September as president of its operating subsidiary in China. He has also worked at Novartis, Bayer and Baxter International.
Client-side people moves courtesy of MM&M sister brand The PMD.
The Escalator is a weekly roundup of notable people moves in the pharmaceutical and healthcare marketing industries. For submissions, email Frank Washkuch at firstname.lastname@example.org.